Home/Filings/4/0001209191-15-056727
4//SEC Filing

Dicerna Pharmaceuticals Inc 4

Accession 0001209191-15-056727

CIK 0001399529operating

Filed

Jun 25, 8:00 PM ET

Accepted

Jun 26, 2:19 PM ET

Size

5.2 KB

Accession

0001209191-15-056727

Insider Transaction Report

Form 4
Period: 2015-06-25
MADDEN DAVID
Director
Transactions
  • Award

    Director Stock Option (right to buy)

    2015-06-25+20,00020,000 total
    Exercise: $13.87Exp: 2025-06-25Common Stock (20,000 underlying)
Footnotes (1)
  • [F1]The option vests in full on June 25, 2016 subject to the Reporting Person's continued service to the Issuer through such date.

Issuer

Dicerna Pharmaceuticals Inc

CIK 0001399529

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001399529

Filing Metadata

Form type
4
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 2:19 PM ET
Size
5.2 KB